Literature DB >> 12799439

The SV40 T antigen modulates CBP histone acetyltransferase activity.

Ester Valls1, Xavier de la Cruz, Marian A Martínez-Balbás.   

Abstract

Histone acetyltransferases (HATs) play a key role in transcription control, cell proliferation and differentiation by modulating chromatin structure; however, little is known about their own regulation. Here we show that expression of the viral oncoprotein SV40 T antigen increases histone acetylation and global cellular HAT activities. In addition, it enhances CREB-binding protein HAT activity and modulates its transcriptional activity. Finally, we show that inhibition of cellular histone deacetylases by trichostatin A increases the SV40 infectivity rate. These findings highlight the importance of histone acetylation in the regulation of the cell cycle by oncoviral proteins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12799439      PMCID: PMC162251          DOI: 10.1093/nar/gkg418

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  47 in total

1.  Characterization of an E1A-CBP interaction defines a novel transcriptional adapter motif (TRAM) in CBP/p300.

Authors:  M J O'Connor; H Zimmermann; S Nielsen; H U Bernard; T Kouzarides
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity.

Authors:  D Chakravarti; V Ogryzko; H Y Kao; A Nash; H Chen; Y Nakatani; R M Evans
Journal:  Cell       Date:  1999-02-05       Impact factor: 41.582

3.  Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A.

Authors:  S Ait-Si-Ali; S Ramirez; F X Barre; F Dkhissi; L Magnaghi-Jaulin; J A Girault; P Robin; M Knibiehler; L L Pritchard; B Ducommun; D Trouche; A Harel-Bellan
Journal:  Nature       Date:  1998-11-12       Impact factor: 49.962

4.  The acetyltransferase activity of CBP stimulates transcription.

Authors:  M A Martinez-Balbás; A J Bannister; K Martin; P Haus-Seuffert; M Meisterernst; T Kouzarides
Journal:  EMBO J       Date:  1998-05-15       Impact factor: 11.598

5.  Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300.

Authors:  H Chen; R J Lin; R L Schiltz; D Chakravarti; A Nash; L Nagy; M L Privalsky; Y Nakatani; R M Evans
Journal:  Cell       Date:  1997-08-08       Impact factor: 41.582

6.  Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain.

Authors:  W Gu; R G Roeder
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

7.  New insights into the mechanism of inhibition of p53 by simian virus 40 large T antigen.

Authors:  H M Sheppard; S I Corneillie; C Espiritu; A Gatti; X Liu
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

8.  Activation of SRF-regulated chromosomal templates by Rho-family GTPases requires a signal that also induces H4 hyperacetylation.

Authors:  A S Alberts; O Geneste; R Treisman
Journal:  Cell       Date:  1998-02-20       Impact factor: 41.582

9.  E1A directly binds and regulates the P/CAF acetyltransferase.

Authors:  J L Reid; A J Bannister; P Zegerman; M A Martínez-Balbás; T Kouzarides
Journal:  EMBO J       Date:  1998-08-03       Impact factor: 11.598

10.  Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein twist and adenoviral oncoprotein E1A.

Authors:  Y Hamamori; V Sartorelli; V Ogryzko; P L Puri; H Y Wu; J Y Wang; Y Nakatani; L Kedes
Journal:  Cell       Date:  1999-02-05       Impact factor: 41.582

View more
  16 in total

1.  Parvovirus nonstructural proteins induce an epigenetic modification through histone acetylation in host genes and revert tumor malignancy to benignancy.

Authors:  Hiroyoshi Iseki; Rie Shimizukawa; Fumihiro Sugiyama; Satoshi Kunita; Atsushi Iwama; Masafumi Onodera; Hiromitsu Nakauchi; Ken-ichi Yagami
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

2.  Role for centromeric heterochromatin and PML nuclear bodies in the cellular response to foreign DNA.

Authors:  Cleo L Bishop; Michal Ramalho; Nachiket Nadkarni; Wing May Kong; Christopher F Higgins; Nina Krauzewicz
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

Review 3.  Life cycle and pathogenesis of hepatitis D virus: A review.

Authors:  Zaigham Abbas; Rafia Afzal
Journal:  World J Hepatol       Date:  2013-12-27

4.  Targeting of p300/CREB binding protein coactivators by simian virus 40 is mediated through p53.

Authors:  Darrell R Borger; James A DeCaprio
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

5.  p53 targets simian virus 40 large T antigen for acetylation by CBP.

Authors:  Danielle L Poulin; Andrew L Kung; James A DeCaprio
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

6.  Genotyping schemes for polyomavirus BK, using gene-specific phylogenetic trees and single nucleotide polymorphism analysis.

Authors:  Chunqing Luo; Marta Bueno; Jeffrey Kant; Jeremy Martinson; Parmjeet Randhawa
Journal:  J Virol       Date:  2008-12-24       Impact factor: 5.103

Review 7.  The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases.

Authors:  Xiang-Jiao Yang
Journal:  Nucleic Acids Res       Date:  2004-02-11       Impact factor: 16.971

8.  Biologic diversity of polyomavirus BK genomic sequences: Implications for molecular diagnostic laboratories.

Authors:  C Luo; M Bueno; J Kant; P Randhawa
Journal:  J Med Virol       Date:  2008-10       Impact factor: 2.327

9.  Two independent regions of simian virus 40 T antigen increase CBP/p300 levels, alter patterns of cellular histone acetylation, and immortalize primary cells.

Authors:  Maria Teresa Sáenz Robles; Chikdu Shivalila; Jeremy Wano; Shelly Sorrells; Alison Roos; James M Pipas
Journal:  J Virol       Date:  2013-10-02       Impact factor: 5.103

10.  CK2-mediated phosphorylation of Che-1/AATF is required for its pro-proliferative activity.

Authors:  Valeria Catena; Tiziana Bruno; Simona Iezzi; Silvia Matteoni; Annalisa Salis; Cristina Sorino; Gianluca Damonte; Maurizio Fanciulli
Journal:  J Exp Clin Cancer Res       Date:  2021-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.